Elimination of cervical cancer: challenges for developing countries.

With both minority populations in the US and Australia sharing a disproportionate risk for developing cervical cancer, the disparity in completion rates may not be significant if one dose of the vaccine provides equivalent immunogenic impact, as has been suggested by Schiller and Lowy [ 30 ].

also in 2,774 other papers